Sharps Technology
STSS
Market cap $4.76M

2.65 USD

-0.16

5.69%

At close Nov 15, 4:00 PM EST

Pre-market

2.59

-0.06

2.26%

1 day

-5.69%

5 days

-2.57%

1 month

-14.79%

3 months

-50.37%

6 months

-42.64%

Year to date

-69.95%

1 year

-71.51%

5 years

-94.29%

10 years

-94.29%

About: Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes are designed to eliminate potentially infectious and accidental needlestick injuries.

Employees: 57

Healthcare Surgical & Medical Instruments & Apparatus

0

Funds holding %

of 6,704 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0% more funds holding

Funds holding: 11 [Q2] → 11 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0.15% less ownership

Funds ownership: 2.94% [Q2] → 2.79% (-0.15%) [Q3]

29% less capital invested

Capital invested by funds: $169K [Q2] → $119K (-$49.3K) [Q3]

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for STSS.

See Analyst Rankings

Financial journalist opinion

Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it will effect a one-for-22 reverse stock split (the "reverse split") of its common stock, par value $0.0001 per share (the "Common Stock"), that will become effective on October 15, 2024 at 11:59 PM Eastern Time, before the opening of trading on The Nasdaq Capital Market ("Nasdaq"). Sharps has requested that its Common Stock begin trading on October 16, 2024, on a post-reverse split basis on the Nasdaq under the existing symbol "STSS".

Sharps Technology, Inc. Announces Stockholders' Approval of Reverse Stock Split Ratio and Effective Date

Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, is reminding shareholders to vote their proxy in favor of the Company's proposal before the shareholder meeting scheduled to be held on October 7, 2024 at 10:00 a.m. Eastern Time.

Sharps Technology, Inc. Reminds Shareholders to Vote Before Important Shareholder Meeting on October 7, 2024

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS). About Sharps Technology, Inc. Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.5 Million Bridge Financing for Sharps Technology, Inc. (NASDAQ:STSS)

Sharps Technology, Inc. Closes $3.5 Million Bridge Financing

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced the closing of its previously announced secured bridge loan financing (the “Bridge Financing”) of approximately $3.5 million.

Sharps Technology, Inc. Closes $3.5 Million Bridge Financing

Sharps Technology, Inc. Announces $3.5 Million Bridge Financing

NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: STSS) (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, today announced that it has entered into definitive agreements with institutional investors for a secured bridge loan financing (the “Bridge Financing”) of approximately $3.5 million.

Sharps Technology, Inc. Announces $3.5 Million Bridge Financing

Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders' Meeting

NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, announced today that the Company has secured approval from The Nasdaq Stock Market (“Nasdaq” or the “Exchange”) to maintain its listing, subject to conditions outlined below.

Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders' Meeting

Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline

Robert Hayes issues a letter to shareholders asking their voting approval on three proposals vital to the Company's continued growth.

Sharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting Deadline

What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?

Shares of Sharps Technology Inc STSS are trading higher on Friday, with a heavy session volume of 15.17 million.

What's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?

Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery

Swiss-based provider of cosmetic, dental, and ophthalmic injectable therapies issues purchase orders for 1mL SecureGard ultra-low waste, smart safety syringes

Sharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 Delivery

Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024

All shareholders of record as of May 17, 2024 are eligible to vote Final votes must be cast by 11:59 p.m., Eastern Time on July 12, 2024 NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW') (the “Company”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class syringe products, encourages its shareholders to participate actively in the upcoming special meeting of stockholders to be held on July 15, 2024 at 10:00 a.m.

Sharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024

See News Rankings

Charts implemented using Lightweight Charts™